Radiopharmaceutical Market Report

Europe Radiopharmaceutical Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 26, 2020
  • PAGES：171
  • REPORT CODE：GMM588579
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Radiopharmaceutical market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 15.1% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Radiopharmaceutical Market Segmentations:

    By Player:

    • Bracco Imaging

    • Nordion

    • Mallinckrodt

    • GE Healthcare

    • IBA Group

    • Navidea

    • Jubilant Pharma

    • Triad Isotopes

    • Eli Lilly

    • Bayer

    • Lantheus

    • SIEMENS

    By Type:

    • SPECT Radioisotopes

    • PET Radioisotopes

    • Other Diagnostic Radioisotopes

    • Therapeutic Radioisotopes

    By End-User:

    • Oncology

    • Cardiology

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Radiopharmaceutical Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Radiopharmaceutical Market Size and Growth Rate of SPECT Radioisotopes from 2014 to 2026

    • 1.3.2 Europe Radiopharmaceutical Market Size and Growth Rate of PET Radioisotopes from 2014 to 2026

    • 1.3.3 Europe Radiopharmaceutical Market Size and Growth Rate of Other Diagnostic Radioisotopes from 2014 to 2026

    • 1.3.4 Europe Radiopharmaceutical Market Size and Growth Rate of Therapeutic Radioisotopes from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Radiopharmaceutical Market Size and Growth Rate of Oncology from 2014 to 2026

    • 1.4.2 Europe Radiopharmaceutical Market Size and Growth Rate of Cardiology from 2014 to 2026

    • 1.4.3 Europe Radiopharmaceutical Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Radiopharmaceutical Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Radiopharmaceutical by Major Types

      • 3.4.1 Market Size and Growth Rate of SPECT Radioisotopes

      • 3.4.2 Market Size and Growth Rate of PET Radioisotopes

      • 3.4.3 Market Size and Growth Rate of Other Diagnostic Radioisotopes

      • 3.4.4 Market Size and Growth Rate of Therapeutic Radioisotopes

    4 Segmentation of Radiopharmaceutical Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Radiopharmaceutical by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oncology for Construction

      • 4.4.2 Market Size and Growth Rate of Cardiology for Construction

      • 4.4.3 Market Size and Growth Rate of Others for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Radiopharmaceutical Production Analysis by Top Regions

    • 5.2 Europe Radiopharmaceutical Consumption Analysis by Top Regions

    • 5.3 Europe Radiopharmaceutical Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.3 France Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Radiopharmaceutical Production, Import, Consumption and Export Analysis

    6 Product Circulation of Radiopharmaceutical Market among Top Countries

    • 6.1 Top 5 Export Countries in Radiopharmaceutical Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Radiopharmaceutical Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Radiopharmaceutical Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Radiopharmaceutical Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Radiopharmaceutical Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Radiopharmaceutical Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Radiopharmaceutical Landscape Analysis

    • 7.1 Germany Radiopharmaceutical Landscape Analysis by Major Types

    • 7.2 Germany Radiopharmaceutical Landscape Analysis by Major End-Users

    8. UK Radiopharmaceutical Landscape Analysis

    • 8.1 UK Radiopharmaceutical Landscape Analysis by Major Types

    • 8.2 UK Radiopharmaceutical Landscape Analysis by Major End-Users

    9. France Radiopharmaceutical Landscape Analysis

    • 9.1 France Radiopharmaceutical Landscape Analysis by Major Types

    • 9.2 France Radiopharmaceutical Landscape Analysis by Major End-Users

    10. Italy Radiopharmaceutical Landscape Analysis

    • 10.1 Italy Radiopharmaceutical Landscape Analysis by Major Types

    • 10.2 Italy Radiopharmaceutical Landscape Analysis by Major End-Users

    11. Spain Radiopharmaceutical Landscape Analysis

    • 11.1 Spain Radiopharmaceutical Landscape Analysis by Major Types

    • 11.2 Spain Radiopharmaceutical Landscape Analysis by Major End-Users

    12. Poland Radiopharmaceutical Landscape Analysis

    • 12.1 Poland Radiopharmaceutical Landscape Analysis by Major Types

    • 12.2 Poland Radiopharmaceutical Landscape Analysis by Major End-Users

    13. Russia Radiopharmaceutical Landscape Analysis

    • 13.1 Russia Radiopharmaceutical Landscape Analysis by Major Types

    • 13.2 Russia Radiopharmaceutical Landscape Analysis by Major End-Users

    14. Switzerland Radiopharmaceutical Landscape Analysis

    • 14.1 Switzerland Radiopharmaceutical Landscape Analysis by Major Types

    • 14.2 Switzerland Radiopharmaceutical Landscape Analysis by Major End-Users

    15. Turkey Radiopharmaceutical Landscape Analysis

    • 15.1 Turkey Radiopharmaceutical Landscape Analysis by Major Types

    • 15.2 Turkey Radiopharmaceutical Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Radiopharmaceutical Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Radiopharmaceutical Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Radiopharmaceutical Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Radiopharmaceutical Landscape Analysis by Top Countries

      • 16.3.1 Denmark Radiopharmaceutical Market Volume and Growth Rate

      • 16.3.2 Finland Radiopharmaceutical Market Volume and Growth Rate

      • 16.3.3 Norway Radiopharmaceutical Market Volume and Growth Rate

      • 16.3.4 Sweden Radiopharmaceutical Market Volume and Growth Rate

      • 16.3.6 Iceland Radiopharmaceutical Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Radiopharmaceutical Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Radiopharmaceutical Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Radiopharmaceutical Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Radiopharmaceutical Landscape Analysis by Top Countries

      • 17.3.1 Belgium Radiopharmaceutical Market Volume and Growth Rate

      • 17.3.2 Netherlands Radiopharmaceutical Market Volume and Growth Rate

      • 17.3.3 Luxembourg Radiopharmaceutical Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Radiopharmaceutical Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Radiopharmaceutical Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Radiopharmaceutical Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Radiopharmaceutical Landscape Analysis by Top Countries

      • 18.3.1 Estonia Radiopharmaceutical Market Volume and Growth Rate

      • 18.3.2 Latvia Radiopharmaceutical Market Volume and Growth Rate

      • 18.3.3 Lithuania Radiopharmaceutical Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Bracco Imaging

      • 19.1.1 Bracco Imaging Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Nordion

      • 19.2.1 Nordion Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Mallinckrodt

      • 19.3.1 Mallinckrodt Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 GE Healthcare

      • 19.4.1 GE Healthcare Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 IBA Group

      • 19.5.1 IBA Group Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Navidea

      • 19.6.1 Navidea Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Jubilant Pharma

      • 19.7.1 Jubilant Pharma Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Triad Isotopes

      • 19.8.1 Triad Isotopes Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Eli Lilly

      • 19.9.1 Eli Lilly Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Bayer

      • 19.10.1 Bayer Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Lantheus

      • 19.11.1 Lantheus Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 SIEMENS

      • 19.12.1 SIEMENS Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    The List of Tables and Figures (Totals 123 Figures and 169 Tables)

    • Figure Product Picture

    • Figure Radiopharmaceutical Market Size and Growth Rate of SPECT Radioisotopes Market, 2015 - 2026 (USD Million)

    • Figure Radiopharmaceutical Market Size and Growth Rate of PET Radioisotopes Market, 2015 - 2026 (USD Million)

    • Figure Radiopharmaceutical Market Size and Growth Rate of Other Diagnostic Radioisotopes Market, 2015 - 2026 (USD Million)

    • Figure Radiopharmaceutical Market Size and Growth Rate of Therapeutic Radioisotopes Market, 2015 - 2026 (USD Million)

    • Figure Radiopharmaceutical Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Radiopharmaceutical Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Radiopharmaceutical Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure UK Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure France Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Radiopharmaceutical Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Radiopharmaceutical

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Radiopharmaceutical by Different Types from 2014 to 2026

    • Table Consumption Share of Radiopharmaceutical by Different Types from 2014 to 2026

    • Figure Radiopharmaceutical Market Size and Growth Rate of SPECT Radioisotopes Market, 2015 - 2026 (USD Million)

    • Figure Radiopharmaceutical Market Size and Growth Rate of PET Radioisotopes Market, 2015 - 2026 (USD Million)

    • Figure Radiopharmaceutical Market Size and Growth Rate of Other Diagnostic Radioisotopes Market, 2015 - 2026 (USD Million)

    • Figure Radiopharmaceutical Market Size and Growth Rate of Therapeutic Radioisotopes Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Radiopharmaceutical by Different End-Users from 2014 to 2026

    • Table Consumption Share of Radiopharmaceutical by Different End-Users from 2014 to 2026

    • Figure Radiopharmaceutical Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Radiopharmaceutical Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Radiopharmaceutical Market Size and Growth Rate of Others from 2014 to 2026

    • Table Europe Radiopharmaceutical Production by Major Regions

    • Table Europe Radiopharmaceutical Production Share by Major Regions

    • Figure Europe Radiopharmaceutical Production Share by Major Countries and Regions in 2014

    • Table Europe Radiopharmaceutical Consumption by Major Regions

    • Table Europe Radiopharmaceutical Consumption Share by Major Regions

    • Table Germany Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table UK Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table France Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Italy Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Spain Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Poland Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Russia Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Switzerland Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Turkey Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Radiopharmaceutical Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Radiopharmaceutical Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Radiopharmaceutical Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Radiopharmaceutical Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Germany Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Germany Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Germany Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table UK Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table UK Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table UK Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table UK Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table France Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table France Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table France Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table France Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Italy Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Italy Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Italy Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Italy Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Spain Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Spain Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Spain Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Spain Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Poland Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Poland Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Poland Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Poland Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Russia Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Russia Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Russia Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Russia Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Switzerland Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Switzerland Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Switzerland Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Turkey Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Turkey Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Turkey Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Radiopharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Radiopharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Radiopharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Radiopharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Radiopharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Radiopharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Bracco Imaging Profiles

    • Table Bracco Imaging Production, Value, Price, Gross Margin 2014-2019

    • Table Bracco Imaging Product benchmarking

    • Table Bracco Imaging Strategic initiatives

    • Table Bracco Imaging SWOT analysis

    • Table Nordion Profiles

    • Table Nordion Production, Value, Price, Gross Margin 2014-2019

    • Table Nordion Product benchmarking

    • Table Nordion Strategic initiatives

    • Table Nordion SWOT analysis

    • Table Mallinckrodt Profiles

    • Table Mallinckrodt Production, Value, Price, Gross Margin 2014-2019

    • Table Mallinckrodt Product benchmarking

    • Table Mallinckrodt Strategic initiatives

    • Table Mallinckrodt SWOT analysis

    • Table GE Healthcare Profiles

    • Table GE Healthcare Production, Value, Price, Gross Margin 2014-2019

    • Table GE Healthcare Product benchmarking

    • Table GE Healthcare Strategic initiatives

    • Table GE Healthcare SWOT analysis

    • Table IBA Group Profiles

    • Table IBA Group Production, Value, Price, Gross Margin 2014-2019

    • Table IBA Group Product benchmarking

    • Table IBA Group Strategic initiatives

    • Table IBA Group SWOT analysis

    • Table Navidea Profiles

    • Table Navidea Production, Value, Price, Gross Margin 2014-2019

    • Table Navidea Product benchmarking

    • Table Navidea Strategic initiatives

    • Table Navidea SWOT analysis

    • Table Jubilant Pharma Profiles

    • Table Jubilant Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Jubilant Pharma Product benchmarking

    • Table Jubilant Pharma Strategic initiatives

    • Table Jubilant Pharma SWOT analysis

    • Table Triad Isotopes Profiles

    • Table Triad Isotopes Production, Value, Price, Gross Margin 2014-2019

    • Table Triad Isotopes Product benchmarking

    • Table Triad Isotopes Strategic initiatives

    • Table Triad Isotopes SWOT analysis

    • Table Eli Lilly Profiles

    • Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019

    • Table Eli Lilly Product benchmarking

    • Table Eli Lilly Strategic initiatives

    • Table Eli Lilly SWOT analysis

    • Table Bayer Profiles

    • Table Bayer Production, Value, Price, Gross Margin 2014-2019

    • Table Bayer Product benchmarking

    • Table Bayer Strategic initiatives

    • Table Bayer SWOT analysis

    • Table Lantheus Profiles

    • Table Lantheus Production, Value, Price, Gross Margin 2014-2019

    • Table Lantheus Product benchmarking

    • Table Lantheus Strategic initiatives

    • Table Lantheus SWOT analysis

    • Table SIEMENS Profiles

    • Table SIEMENS Production, Value, Price, Gross Margin 2014-2019

    • Table SIEMENS Product benchmarking

    • Table SIEMENS Strategic initiatives

    • Table SIEMENS SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US